Facebook Linkedin Twitter
Inside Precision Medicine YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Lymphoma

Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
Oncology

YTHDF2 in B Cell Malignancies: A New Pathway to Enhanced Immunotherapy

Alice McCarthy
0
Close up image of a lymphoma cancer cell that can be targeted with CAR T-cell therapy
News & Features

Mantle Cell Lymphoma Patients May Not Need Stem Cell Transplant

0
Hodgkin lymphoma, light micrograph
News & Features

Lab-Grown Human Immune System Can Check Cancer Patients’ Immune Responses

0
Lymphocytes and biomedical concept, 3d rendering.
News & Features

First Patient Dosed with In Vivo Gene Therapy for CAR T

Jonathan D. Grinstein, PhD
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

On/Off Switch for CAR-T Cell Therapy Shows Early Promise

0
Lymphoma cancer cell that can be targeted by CAR T-cell therapy
News & Features

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma

Alice McCarthy
0
CAR T cell immunotherapy, illustration
News & Features

Outpatient CAR T Therapy Is Safe and Effective in Community Setting

0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

Shortening of CAR-T Cell Monitoring Period Could Improve Accessibility

0
HIV viruses, illustration
News & Features

Second HIV Patient “Cured” with Stem Cell Transplant at Charité, Using Slightly Different Genetic Recipe

0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

0
123...8Page 1 of 8

Related Content

Sage Publishing

Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy

Sage Publishing
Inside Precision Medicine